A8327
Albumin -Lösung
30%±2% in 0.85% sodium chloride, aseptically filled
Synonym(e):
Albumin -Lösung aus Rinderserum, BSA-Lösung
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(2)
About This Item
Empfohlene Produkte
Biologische Quelle
bovine
Qualitätsniveau
Sterilität
aseptically filled
Assay
28-32% protein basis (biuret)
Form
solution
Aufgereinigt durch
heat shock fractionation
Enthält nicht
stabilizer or preservative
Ursprung
USA origin
Konzentration
28-32% protein (biuret)
30%±2% in 0.85% sodium chloride
Methode(n)
ELISA: suitable
UniProt-Hinterlegungsnummer
Lagertemp.
2-8°C
Angaben zum Gen
bovine ... ALB(280717)
Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich
Allgemeine Beschreibung
Serum Albumin is a protein widely present in the circulating blood. Albumin has a helical structure with three domains that form a heart-like shape. It belongs to the four-member albumin superfamily.
Anwendung
Bovine Serum Albumin solution has been used:
- as one of the experimental components to resemble the plasma-protein-rich acute respiratory distress syndrome (ARDS) edema liquid
- to prepare embryos for fluorescent staining of the actin cytoskeleton
- in tissue culture and neurite outgrowth assay
Biochem./physiol. Wirkung
Serum Albumin regulates the osmotic pressure and pH of the blood. It transports various endogenous and exogenous compounds such as amino acids, drugs, steroids, and fatty acids. Bovine serum albumin (BSA) serves as a molecular weight standard, standard in vaccine preparation, and enzyme-linked immunosorbent assay (ELISA).
Lagerklassenschlüssel
10 - Combustible liquids
WGK
WGK 3
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Persönliche Schutzausrüstung
Eyeshields, Gloves
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Kunden haben sich ebenfalls angesehen
Ching-Lin Hsieh et al.
Cell reports, 37(5), 109929-109929 (2021-10-29)
Current coronavirus (CoV) vaccines primarily target immunodominant epitopes in the S1 subunit, which are poorly conserved and susceptible to escape mutations, thus threatening vaccine efficacy. Here, we use structure-guided protein engineering to remove the S1 subunit from the Middle East
Umma Habiba et al.
Oncology letters, 13(1), 321-328 (2017-01-27)
Oral leukoplakia (OL) is a clinically diagnosed preneoplastic lesion of the oral cavity with an increased oral cancer risk. However, the risk of malignant transformation is still difficult to assess. The objective of the present study was to examine the
André G Costa-Martins et al.
Cell reports. Medicine, 2(12), 100465-100465 (2022-01-15)
In children lacking influenza-specific adaptive immunity, upper respiratory tract innate immune responses may influence viral replication and disease outcome. We use trivalent live attenuated influenza vaccine (LAIV) as a surrogate challenge model in children aged 24-59 months to identify pre-infection mucosal
Kushal Suryamohan et al.
Communications biology, 4(1), 475-475 (2021-04-14)
COVID-19 is a respiratory illness caused by a novel coronavirus called SARS-CoV-2. The viral spike (S) protein engages the human angiotensin-converting enzyme 2 (ACE2) receptor to invade host cells with ~10-15-fold higher affinity compared to SARS-CoV S-protein, making it highly
M Gordon Joyce et al.
Cell reports, 37(12), 110143-110143 (2021-12-18)
The need for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) next-generation vaccines has been highlighted by the rise of variants of concern (VoCs) and the long-term threat of emerging coronaviruses. Here, we design and characterize four categories of engineered nanoparticle
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.